INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 25 filers reported holding INHIBIKASE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165,458 | +163.0% | 251,610 | +100.0% | 0.03% | +26.1% |
| Q4 2022 | $62,903 | -43.3% | 125,805 | +2.7% | 0.02% | -43.9% |
| Q3 2022 | $111,000 | +22.0% | 122,477 | -0.2% | 0.04% | +24.2% |
| Q2 2022 | $91,000 | -50.0% | 122,682 | 0.0% | 0.03% | -38.9% |
| Q1 2022 | $182,000 | – | 122,682 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 1,010,000 | $1,919,000 | 1.00% |
| Murchinson Ltd. | 320,947 | $610,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 425,014 | $808,000 | 0.11% |
| Kepos Capital LP | 700,000 | $1,330,000 | 0.09% |
| Antara Capital LP | 303,000 | $576,000 | 0.04% |
| ZEKE CAPITAL ADVISORS, LLC | 93,800 | $178,000 | 0.01% |
| Warberg Asset Management LLC | 26,000 | $49,000 | 0.01% |
| Shay Capital LLC | 20,000 | $38,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 122 | $0 | 0.00% |
| NORTHERN TRUST CORP | 15,714 | $30,000 | 0.00% |